Beta Bionics, Inc. (BBNX)
19.42
-0.50
(-2.51%)
USD |
NASDAQ |
Sep 04, 16:00
19.41
-0.01
(-0.05%)
After-Hours: 20:00
Beta Bionics Gross Profit Margin (Quarterly) : 59.04% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 59.04% |
| March 31, 2026 | 59.50% |
| December 31, 2025 | 58.98% |
| September 30, 2025 | 55.48% |
| June 30, 2025 | 53.80% |
| March 31, 2025 | 50.86% |
| Date | Value |
|---|---|
| December 31, 2024 | 57.19% |
| September 30, 2024 | 53.36% |
| June 30, 2024 | 53.73% |
| March 31, 2024 | 55.68% |
| December 31, 2023 | 60.62% |
| September 30, 2023 | 39.61% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Enovis Corp. | 54.51% |
| Edwards Lifesciences Corp. | 78.09% |
| Intuitive Surgical, Inc. | 67.76% |
| Kewaunee Scientific Corp. | 29.75% |
| STAAR Surgical Co. | 71.98% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -25.85% |
| Return on Assets | -23.01% |
| Return on Invested Capital | -25.22% |
| Profit Margin (Quarterly) | -73.10% |
| Operating Margin (Quarterly) | -79.90% |
| Return on Net Operating Assets | -126.5% |